- Home
- LTC vs HRMY Comparison
LTC vs HRMY Comparison
Compare LTC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTC
- HRMY
- Stock Information
- Founded
- LTC 1992
- HRMY 2017
- Country
- LTC United States
- HRMY United States
- Employees
- LTC N/A
- HRMY N/A
- Industry
- LTC Real Estate Investment Trusts
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- LTC Real Estate
- HRMY Health Care
- Exchange
- LTC Nasdaq
- HRMY Nasdaq
- Market Cap
- LTC 1.6B
- HRMY 1.8B
- IPO Year
- LTC 1992
- HRMY 2020
- Fundamental
- Price
- LTC $35.20
- HRMY $34.27
- Analyst Decision
- LTC Hold
- HRMY Strong Buy
- Analyst Count
- LTC 5
- HRMY 9
- Target Price
- LTC $37.80
- HRMY $55.33
- AVG Volume (30 Days)
- LTC 399.9K
- HRMY 590.1K
- Earning Date
- LTC 08-04-2025
- HRMY 08-05-2025
- Dividend Yield
- LTC 6.56%
- HRMY N/A
- EPS Growth
- LTC 0.36
- HRMY 13.13
- EPS
- LTC 1.93
- HRMY 2.62
- Revenue
- LTC $202,686,000.00
- HRMY $744,852,000.00
- Revenue This Year
- LTC N/A
- HRMY $20.45
- Revenue Next Year
- LTC $11.85
- HRMY $17.32
- P/E Ratio
- LTC $17.99
- HRMY $13.56
- Revenue Growth
- LTC 3.98
- HRMY 20.62
- 52 Week Low
- LTC $31.70
- HRMY $26.47
- 52 Week High
- LTC $39.89
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- LTC 43.64
- HRMY 46.70
- Support Level
- LTC $33.89
- HRMY $34.09
- Resistance Level
- LTC $34.82
- HRMY $36.09
- Average True Range (ATR)
- LTC 0.60
- HRMY 1.37
- MACD
- LTC -0.08
- HRMY -0.23
- Stochastic Oscillator
- LTC 26.21
- HRMY 33.05
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.